The EPISTOP project recently has been presented at the STSN (Stichting Tubereuze Sclerose Nederland) symposium by prof. dr. E. Aronica and at the "2nd meeting on inflammation and immunity in epilepsy" in Milan by prof. dr. S. Jozwiak.

epistop dissemination

EPISTOP presented on IIE 2016 Milaan

We are pleased to inform that we have finished the recruitment period in EPISTOP project with 101 patients included to the study. Thanks to involvement of all clinical sites our recruitment goal (100 patients) has been achieved. Now we continue with the follow-up of our patients to provide the best care and obtain high quality clinical data.

The 2nd Steering Committee Meeting within the EPISTOP project took place on June 17-18, 2016 in Amsterdam, The Netherlands. The meeting was moderated by prof. Eleonora Aronica and attended by all work package leaders. During this meeting, the progress and issues of each work package were presented. 

5 patients joined the EPISTOP study recently – 2 in Poland, 1 in the Netherlands, 1 in Germany and 1 in France. All together we included 86 patients to the study already.

Recently a new patient joined the study in Prague. In total we have now 81 patients and still 3 months left until the end of the recruitment period.